Genetic diagnosis improves patient care for rare diseases
Genetic testing can provide a crucial diagnosis for children with rare diseases and their families. An identified diagnosis allows for more personalized care and better follow-up.
Fast Company highlights that genetic testing is revolutionizing the diagnosis and treatment of rare and genetic diseases. The company emphasizes that obtaining a diagnosis is just the beginning of a journey, but it enables significantly better and more targeted care.
When the genetic cause of a child's symptoms is identified through genetic testing, clinicians can make more informed treatment decisions. This can involve selecting the right medications, anticipating complications, avoiding unnecessary tests, and connecting patients with the appropriate specialists and support groups. For instance, in epilepsy treatment, identifying the genetic cause can directly influence medication and the treatment plan.
The diagnosis also offers significant relief to families. After years of specialist appointments and searching for answers, knowing the cause of their child's condition helps parents better understand their child's health and make informed decisions about therapies, educational services, and long-term planning. Additionally, it can connect families with others in similar situations and with support organizations.
According to Fast Company, the significance of diagnostics is now measured not only by how often an answer is found but also by what happens after the diagnosis. Studies show that when the underlying condition is known, patients experience fewer hospitalizations and emergency visits. This shift from reactive to proactive management improves patient outcomes and reduces healthcare costs.